The company — headquartered in Dangan, Galway — expects its investment to create 725 new jobs in Ireland over the next 10 years. According to Enterprise Ireland, the aerosol drug delivery company is Ireland’s largest indigenous medtech company.
Aerogen has more than 25 years of experience, 300 international patents and more than 200 clinical papers. Its technology has been used to treat more than 25 million patients in emergency departments, adult and paediatric ICUs, general wards and ambulance services in 75 countries worldwide.
The company offers a safe, powerful drug delivery device for the treatment of critical respiratory illness and other non-respiratory illnesses. Enterprise Ireland labels it the leading manufacturer of high-performance, single-use respiratory nebulizers in the world.
According to a news release, the new Irish jobs at Aerogen span R&D, manufacturing, science and engineering. The company plans to add jobs at both its manufacturing sites in Parkmore, Galway, and in Shannon. It expects to create up to 725 highly skilled jobs in the region by 2035, increasing its global workforce to over 2,000. Of that workforce, it anticipates having more than 1,100 based in Ireland.
The company plans to accelerate its existing device technology and build its emerging biopharmaceuticals business.
“We are delighted to announce this continued expansion of Aerogen as a truly global life science company. Enterprise Ireland have been a superb partner in supporting this journey on which we just reached the pivotal milestone of having treated our 25th millionth patient, and we will continue to innovate across the respiratory journey for patients from our HQ here in Galway,” said John Power, Aerogen founder and CEO.
